GCKIII kinases control hepatocellular lipid homeostasis via shared mode of action by Emmelie Cansby, Mara Caputo, Emma Andersson, Rasool Saghaleyni, Marcus Henricsson, Ying Xia, Bernice Asiedu, Matthias Blüher, L. Thomas Svensson, Andrew J. Hoy, Margit Mahlapuu

Subjects: “…MASLD…”
Get full text

Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023 by Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed

Subjects: “…masld…”
Get full text

Mini-review: Serum immunoglobulins and MASLD by Ke-qian Chen, Wen-jing Cao, Shu-zhi Wang, Wei Li

Subjects: Get full text

Editorial: Nutriomic analysis of food and functional compounds for MAFLD prevention by Fermin I. Milagro, Fermin I. Milagro, Fermin I. Milagro, Fermin I. Milagro, Claudio A. Bernal, Claudio A. Bernal, Claudio A. Bernal

Subjects: Get full text

Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials by Hazem Ayesh, Azizullah Beran, Sajida Suhail, Suhail Ayesh, Kevin Niswender

Subjects: Get full text

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease by Dandan Yang, Dandan Yang, Hongsheng Dai, Yulu Wang, Jiayi Zhang, Min Wei, Ming Shan, Ming Shan, Xiaoqian Zhang

Subjects: “…MASLD…”
Get full text

Multidimensional sleep impairment predicts steatotic liver disease spectrum risk by Dongling Wang, Xiao Zhang, Yujie Cai, Haihang Dong, Yinqiang Zhang

Subjects: Get full text

Applicability of Statins in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Thaninee Prasoppokakorn

Subjects: Get full text

The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease by Clément J. F. Heymann, Anne Linde Mak, Adriaan G. Holleboom, Joanne Verheij, Ronit Shiri-Sverdlov, Saskia W. C. van Mil, Maarten E. Tushuizen, Ger H. Koek, Aldo Grefhorst

Subjects: Get full text

A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease by Zülal İstemihan, Fatih Bektaş, Ali Emre Bardak, Cansu Kızıltaş, Gamze Kemeç, Ziya İmanov, İbrahim Volkan Şenkal, Kanan Nuriyev, Aynura Rustamzade, Sezen Genç Uluçeçen, Hülya Hacisahinogullari, Kubilay Karşıdağ, Bilger Çavuş, Aslı Çifcibaşı Örmeci, Filiz Akyüz, Kadir Demir, Fatih Beşışık, Sabahattin Kaymakoğlu

Subjects: “…MASLD…”
Get full text

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications by Farah Abdelhameed, Attia Mustafa, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Nwe Ni Than, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva

Subjects: “…MASLD…”
Get full text

Serum Mac-2 binding protein glycosylation isomer as a biomarker for metabolic dysfunction associated steatotic liver disease by Ahmed M. F. Mansour, Ehab Nashaat, Asmaa Gouda Seliem Hassan Mohamed, Ahmed Mohamed ElGhandour

Subjects: Get full text

M6A methyltransferase METTL3 promotes glucose metabolism hub gene expression and induces metabolic dysfunction-associated steatotic liver disease (MASLD) by Shuowen Wang, Ziying Xu, Zijun Wang, Xiaoyu Yi, Jianxin Wu

Subjects: “…MASLD…”
Get full text

Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with No... by Mona Hassan, Nooraldin Merza, Yusuf Nawras, Halah Alfatlawi, hasan al obaidi, Omar Saab, Khalid Al Zubaidi, Daniah Al-sabbagh, Sarmed mansur, Marwah Algodi, Omer Al Najafi, Rand Matbachi, Tamarah Al Hamdany, Zainab Noori, Abdallah Kobeissy

Subjects: “…MASLD…”
Get full text

Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation by Xiaoyu Lv, Chenyu Nie, Yihan Shi, Qincheng Qiao, Jing Gao, Ying Zou, Jingwen Yang, Li Chen, Xinguo Hou

Subjects: Get full text

Association between the lymphocyte-to-high-density lipoprotein ratio and metabolic dysfunction-associated steatotic liver disease among US adults: a cross-sectional study from NHAN... by Chuanzhi Tang, Dadi Peng, Kezhen Zong, Zhongjun Wu, Miao Gong, Hui Li, Zuotian Huang, Shanshan Li

Subjects: “…MASLD…”
Get full text

Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems by Diwakar Suresh, Bharathwaaj Gunaseelan, Akshatha N. Srinivas, Amith Bharadwaj, James Joseph, Megha, Thomas Varughese, Suchitha Satish, Deepak Suvarna, Prasanna K. Santhekadur, Saravana Babu Chidambaram, Ajay Duseja, Divya P. Kumar

Subjects: Get full text

Racial and Ethnic Disparities in NAFLD: Harnessing Epigenetic and Gut Microbiota Pathways for Targeted Therapeutic Approaches by Mohamed Zaiou, Olivier Joubert

Subjects: Get full text

A Critical Role for the Mitochondrial Pyruvate Carrier in Hepatic Stellate Cell ActivationSummary by Mohammad Habibi, Daniel Ferguson, Sophie J. Eichler, Mandy M. Chan, Christina Fu, Terri A. Pietka, Andrea L. Bredemeyer, Andrew LaPoint, Trevor M. Shew, Mai He, Kim H.H. Liss, Andrew J. Lutkewitte, Kevin Cho, Joel D. Schilling, Gary J. Patti, Brian N. Finck

Subjects: Get full text

Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis by Adrian Rotaru, Remus Stafie, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Horia Minea, Laura Huiban, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Catalin Sfarti, Carol Stanciu, Anca Trifan

Subjects: “…MASLD…”
Get full text